Magic mushroom compound at least as good as antidepressant in UK study By Reuters
By Kate Kelland LONDON (Reuters) - Psilocybin, the psychedelic active compound in magic mushrooms, may be at least as effective as a leading antidepressant drug and could help more patients into remission from severe depression, a small study by British scientists has found. The findings, in the first-of-a-kind head-to-head comparison of psilocybin therapy and the antidepressant escitalopram, suggests the psychoactive ingredient has promise as a potential mental health treatment, the researchers said. "Remission rates were twice as high in the psilocybin group than the escitalopram group," Robin Carhart-Harris, who designed and led the study as...
Continue reading